Rheumatoid Arthritis

Sarcopenic Obesity in Osteoarthritis vs Rheumatoid Arthritis

Sarcopenic Obesity in Osteoarthritis vs Rheumatoid Arthritis

By

Individuals with osteoarthritis may exhibit a higher prevalence of sarcopenic obesity, compared with patients with rheumatoid arthritis.

Pneumococcal Vaccination in Patients With Rheumatoid Arthritis: Taking Treatment Into Consideration

Pneumococcal Vaccination in Patients With Rheumatoid Arthritis: Taking Treatment Into Consideration

By

Clinicians conducting pneumococcal vaccination in patients with rheumatoid arthritis should take into consideration the type of RA treatment being used and offer early vaccination.

Tocilizumab Treat-to-Target More Efficacious Than Methotrexate in RA

Tocilizumab Treat-to-Target More Efficacious Than Methotrexate in RA

By

DMARD-naïve patients with rheumatoid arthritis benefited from treat-to-target tocilizumab therapy.

Online Consultation System Benefits Rheumatic Disease Management

Online Consultation System Benefits Rheumatic Disease Management

The SSDM series of applications is cost-effective for patients of rheumatologists.

Adhering to TNFi Therapy May Reduce Joint Replacement Rates in Rheumatoid Arthritis

Adhering to TNFi Therapy May Reduce Joint Replacement Rates in Rheumatoid Arthritis

By

Approval of TNFi therapies for the management of RA indicates a temporal association with reduced rates of total knee replacement surgery.

Medications Linked With Increased Osteoporotic Fracture Risk in Rheumatoid Arthritis

Medications Linked With Increased Osteoporotic Fracture Risk in Rheumatoid Arthritis

Opioids and SSRIs are linked to an increased risk of osteoporotic fractures in RA patients.

Adalimumab to Sarilumab for Rheumatoid Arthritis: Effect on Physical Function

Adalimumab to Sarilumab for Rheumatoid Arthritis: Effect on Physical Function

By

Sarilumab administered every 2 weeks is associated with similar improvements in physical function in adult patients with rheumatoid arthritis, compared with adalimumab.

Sarilumab Plus DMARDs: Effects on Glycemic Control in Comorbid RA and Diabetes

Sarilumab Plus DMARDs: Effects on Glycemic Control in Comorbid RA and Diabetes

By

A combination of sarilumab and DMARDs administered for 24 weeks was shown to effectively reduce fasting glucose and glycosylated hemoglobin in patients with RA, with or without diabetes.

Successful Biologics Tapering in Rheumatoid Arthritis Predicted by Younger Age, CRP Level

Successful Biologics Tapering in Rheumatoid Arthritis Predicted by Younger Age, CRP Level

By

Factors may be predictive of successful tapering of biologics in patients with rheumatoid arthritis who are in remission.

Digital Health Coaching Program Improves Healthy Behaviors, Decreases RA Flares

Digital Health Coaching Program Improves Healthy Behaviors, Decreases RA Flares

By

A behavior modification program can improve healthy behaviors and decrease symptoms of rheumatoid arthritis.

Depression Associated With Disease Activity in Early Rheumatoid Arthritis

Depression Associated With Disease Activity in Early Rheumatoid Arthritis

By

Initial high disease activity in patients with early rheumatoid arthritis is associated with an increased risk for depression and persistent depression.

Temporary Methotrexate Discontinuation Improves Influenza Vaccine Immunogenicity in RA

Temporary Methotrexate Discontinuation Improves Influenza Vaccine Immunogenicity in RA

By

Temporary methotrexate discontinuation after receiving seasonal influenza vaccination improves the immunogenicity of vaccination in patients with rheumatoid arthritis.

Multibiomarker Screen Predicts Radiographic Progression in Rheumatoid Arthritis

Multibiomarker Screen Predicts Radiographic Progression in Rheumatoid Arthritis

By

Data from 6 cohorts were used to evaluate and establish the relationship between multibiomarker disease activity score and radiographic progression risk.

Pregnancy Outcomes in SLE vs Other Connective Tissue, Inflammatory Rheumatic Conditions

Pregnancy Outcomes in SLE vs Other Connective Tissue, Inflammatory Rheumatic Conditions

By

Real-world data indicate that although most patients with systemic lupus erythematosus or connective tissue diseases have successful pregnancies, more adverse pregnancy outcomes occur.

Anemia Associated With Radiographic Progression in Methotrexate-Naïve Patients

Anemia Associated With Radiographic Progression in Methotrexate-Naïve Patients

By

In this post hoc analysis, researchers explored whether anemia was a predictor of radiographic progression in patients with RA who were treated with tofacitinib.

Biologics Show Greater Response Rate After Secondary Response Failure to TNFi in RA

Biologics Show Greater Response Rate After Secondary Response Failure to TNFi in RA

By

Criteria for determining whether a second TNFi or BDMA should be given to patients with secondary failure to TNFi requires further clinical clarification.

Long-Term Safety of Adalimumab in Immune-Related Diseases Analyzed

Long-Term Safety of Adalimumab in Immune-Related Diseases Analyzed

By

Investigators sought to determine the long-term safety of adalimumab use in patients with arthritis and other immune-related diseases.

MRI in Rheumatoid Arthritis: Assessing Disease Activity, Remission, Prognosis

MRI in Rheumatoid Arthritis: Assessing Disease Activity, Remission, Prognosis

By

MRI allows to show changes to bone and cartilage, and to discriminate these from fluid and soft tissues around the joints, making it a good technique for measuring synovial volume and inflammation characteristic of RA.

TNFi Use Not Associated With Increased Cancer Risk in RA

TNFi Use Not Associated With Increased Cancer Risk in RA

By

Patients with rheumatoid arthritis who receive TNF inhibitor treatment do not appear to be at increased risk for overall cancer.

Ultrasound Scoring System for Evaluation of Synovitis of Wrists and Hands in RA

Ultrasound Scoring System for Evaluation of Synovitis of Wrists and Hands in RA

By

A simplified and validated ultrasound scoring system for the evaluation of synovitis in the wrists and hands of patients with rheumatoid arthritis has been proposed.

Assessment of Intracranial Circulation in Rheumatoid Arthritis

Assessment of Intracranial Circulation in Rheumatoid Arthritis

By

This study appears to be the first of its kind to use transcranial Doppler to assess intracranial arteries in rheumatoid arthritis.

Multi-Biomarker Disease Activity Test to Assess Disease Activity in RA

Multi-Biomarker Disease Activity Test to Assess Disease Activity in RA

By

In a real-world registry of patients with rheumatoid arthritis, scores on the multi-biomarker disease activity test were significantly associated with RA disease activity, obesity, and age.

Patients With RA Using DMARDs May Have Higher Risk for Dementia

Patients With RA Using DMARDs May Have Higher Risk for Dementia

By

These results highlight the importance of a multidisciplinary team for treating patients with rheumatoid arthritis.

Predictive Value of Autoantibodies in Clinically Suspect Arthralgia and Risk for RA

Predictive Value of Autoantibodies in Clinically Suspect Arthralgia and Risk for RA

By

The presence of the certain autoantibodies accurately predicts a person's risk for progression from clinically suspect arthralgia to rheumatoid arthritis.

Ketoprofen for Rheumatoid Arthritis Pain: Safe and Effective

Ketoprofen for Rheumatoid Arthritis Pain: Safe and Effective

By

In patients with rheumatoid arthritis, ketoprofen was found to be effective in relieving moderate to severe pain.

More Information About Sirukumab for Active RA Requested by FDA

More Information About Sirukumab for Active RA Requested by FDA

By

The FDA has issued a CRL for the application license of sirukumab.

SB5 vs Adalimumab Efficacy, Safety in Rheumatoid Arthritis

SB5 vs Adalimumab Efficacy, Safety in Rheumatoid Arthritis

By

The efficacy and safety of the biosimilar SB5 appears to be equivalent to that of adalimumab in patients with RA.

Tapering TNF Inhibitors: A Good Strategy for Rheumatoid Arthritis?

Tapering TNF Inhibitors: A Good Strategy for Rheumatoid Arthritis?

By

Lowering tumor necrosis factor inhibitor dosage by one-third yielded excellent results in terms of safety, clinical effectiveness, and tolerability in patients with rheumatoid arthritis.

Increased Cancer Risk for RA Patients With Venous Thromboembolism

Increased Cancer Risk for RA Patients With Venous Thromboembolism

There is an increased risk of cancer for patients with RA and VTE.

Comparison of SB4 and Reference Etanercept in Active Rheumatoid Arthritis

Comparison of SB4 and Reference Etanercept in Active Rheumatoid Arthritis

By

A biosimilar and its reference agent were assessed for efficacy and safety.

Sign Up for Free e-newsletters